Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 349

    1.

    Plasma retinol-binding protein-4 concentrations are elevated in human subjects with impaired glucose tolerance and type 2 diabetes.

    Cho YM, Youn BS, Lee H, Lee N, Min SS, Kwak SH, Lee HK, Park KS.

    Diabetes Care. 2006 Nov;29(11):2457-61.PMID: 17065684 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Retinol-binding protein 4 is associated with impaired glucose tolerance but not with whole body or hepatic insulin resistance in Mexican Americans.

    Chavez AO, Coletta DK, Kamath S, Cromack DT, Monroy A, Folli F, DeFronzo RA, Tripathy D.

    Am J Physiol Endocrinol Metab. 2009 Apr;296(4):E758-64. Epub 2009 Feb 3.PMID: 19190263 [PubMed - indexed for MEDLINE]Related articles

    3.

    Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects.

    Graham TE, Yang Q, Blüher M, Hammarstedt A, Ciaraldi TP, Henry RR, Wason CJ, Oberbach A, Jansson PA, Smith U, Kahn BB.

    N Engl J Med. 2006 Jun 15;354(24):2552-63.PMID: 16775236 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus.

    Choi SH, Kwak SH, Youn BS, Lim S, Park YJ, Lee H, Lee N, Cho YM, Lee HK, Kim YB, Park KS, Jang HC.

    J Clin Endocrinol Metab. 2008 Aug;93(8):3142-8. Epub 2008 May 20.PMID: 18492757 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Retinol-binding protein 4 levels are elevated in polycystic ovary syndrome women with obesity and impaired glucose metabolism.

    Hahn S, Backhaus M, Broecker-Preuss M, Tan S, Dietz T, Kimmig R, Schmidt M, Mann K, Janssen OE.

    Eur J Endocrinol. 2007 Aug;157(2):201-7.PMID: 17656599 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population.

    Xu M, Li XY, Wang JG, Wang XJ, Huang Y, Cheng Q, Huang HE, Li R, Xiang J, Tan JR, Dai M, Ning G.

    Diabetologia. 2009 Aug;52(8):1511-9. Epub 2009 Jun 9.PMID: 19506831 [PubMed - indexed for MEDLINE]Related articles

    7.

    Serum retinal-binding protein 4 is positively related to insulin resistance in Chinese subjects with type 2 diabetes.

    Cheng X, Zhang H.

    Diabetes Res Clin Pract. 2009 Apr;84(1):58-60. Epub 2009 Feb 4.PMID: 19195734 [PubMed - indexed for MEDLINE]Related articles

    8.

    Microalbuminuria is a major determinant of elevated plasma retinol-binding protein 4 in type 2 diabetic patients.

    Raila J, Henze A, Spranger J, Möhlig M, Pfeiffer AF, Schweigert FJ.

    Kidney Int. 2007 Aug;72(4):505-11. Epub 2007 Jun 13.PMID: 17568782 [PubMed - indexed for MEDLINE]Related articles

    9.

    Retinol-binding protein 4 in twins: regulatory mechanisms and impact of circulating and tissue expression levels on insulin secretion and action.

    Ribel-Madsen R, Friedrichsen M, Vaag A, Poulsen P.

    Diabetes. 2009 Jan;58(1):54-60. Epub 2008 Oct 13.PMID: 18852328 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4.

    Yagmur E, Weiskirchen R, Gressner AM, Trautwein C, Tacke F.

    Diabetes Care. 2007 May;30(5):1168-72. Epub 2007 Mar 2.PMID: 17337499 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin-resistant human subjects.

    Graham TE, Wason CJ, Blüher M, Kahn BB.

    Diabetologia. 2007 Apr;50(4):814-23. Epub 2007 Feb 9.PMID: 17294166 [PubMed - indexed for MEDLINE]Related articles

    12.

    Retinol-binding protein 4 is associated with insulin resistance and body fat distribution in nonobese subjects without type 2 diabetes.

    Gavi S, Stuart LM, Kelly P, Melendez MM, Mynarcik DC, Gelato MC, McNurlan MA.

    J Clin Endocrinol Metab. 2007 May;92(5):1886-90. Epub 2007 Feb 13.PMID: 17299074 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Retinol binding protein 4 expression in humans: relationship to insulin resistance, inflammation, and response to pioglitazone.

    Yao-Borengasser A, Varma V, Bodles AM, Rasouli N, Phanavanh B, Lee MJ, Starks T, Kern LM, Spencer HJ 3rd, Rashidi AA, McGehee RE Jr, Fried SK, Kern PA.

    J Clin Endocrinol Metab. 2007 Jul;92(7):2590-7. Epub 2007 Jun 26.PMID: 17595259 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Effects of genetic variation in the human retinol binding protein-4 gene (RBP4) on insulin resistance and fat depot-specific mRNA expression.

    Kovacs P, Geyer M, Berndt J, Klöting N, Graham TE, Böttcher Y, Enigk B, Tönjes A, Schleinitz D, Schön MR, Kahn BB, Blüher M, Stumvoll M.

    Diabetes. 2007 Dec;56(12):3095-100. Epub 2007 Aug 29.PMID: 17728376 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    High circulating retinol-binding protein 4 is associated with elevated liver fat but not with total, subcutaneous, visceral, or intramyocellular fat in humans.

    Stefan N, Hennige AM, Staiger H, Machann J, Schick F, Schleicher E, Fritsche A, Häring HU.

    Diabetes Care. 2007 May;30(5):1173-8. Epub 2007 Jan 26.PMID: 17259477 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Retinol binding protein-4 elevation is associated with serum thyroid-stimulating hormone level independently of obesity in elderly subjects with normal glucose tolerance.

    Choi SH, Lee YJ, Park YJ, Kim KW, Lee EJ, Lim S, Park do J, Kim SE, Park KS, Jang HC, Cho BY.

    J Clin Endocrinol Metab. 2008 Jun;93(6):2313-8. Epub 2008 Apr 1.PMID: 18381580 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Retinol-binding protein 4 as a plasma biomarker of renal dysfunction and cardiovascular disease in type 2 diabetes.

    Cabré A, Lázaro I, Girona J, Manzanares J, Marimón F, Plana N, Heras M, Masana L.

    J Intern Med. 2007 Oct;262(4):496-503.PMID: 17875187 [PubMed - indexed for MEDLINE]Related articles

    18.

    Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients.

    Miyazaki Y, Pipek R, Mandarino LJ, DeFronzo RA.

    Int J Obes Relat Metab Disord. 2003 Jan;27(1):88-94.PMID: 12532159 [PubMed - indexed for MEDLINE]Related articles

    19.

    Plasma interleukin-6 levels are increased in subjects with impaired glucose tolerance but not in those with impaired fasting glucose in a cohort of Italian Caucasians.

    Cardellini M, Andreozzi F, Laratta E, Marini MA, Lauro R, Hribal ML, Perticone F, Sesti G.

    Diabetes Metab Res Rev. 2007 Feb;23(2):141-5.PMID: 16952201 [PubMed - indexed for MEDLINE]Related articles

    20.

    Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT.

    Stefan N, Stumvoll M, Bogardus C, Tataranni PA.

    Am J Physiol Endocrinol Metab. 2003 Jun;284(6):E1156-61. Epub 2003 Feb 11.PMID: 12582008 [PubMed - indexed for MEDLINE]Related articlesFree article